Growth in global spending on medications will slow markedly over the next four years due to a slew of new low-cost generic drugs coming to pharmacies in the U.S. and other developed countries, along with slower increases in what those countries spend on brand-name drugs, according to a new forecast.
Related posts:
Using homegrown tech to quell cyberespionage can backfire
Busted: Biotech Leader ‘Syngenta’ Charged Over Covering Up Animal Deaths from GM Corn
'I helped Lord Lucan live as an African fugitive': Assistant to peer's friend claims she helped Brit...
Lost Airmen of Buchenwald: A Documentary
City University of New York Resolves to Balance Out Anti-Israel “Pinkwashing” Conference
Google’s ‘Augmented Reality’ Glasses: Not Creepy At All
Views: 0